Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567496/
https://www.ncbi.nlm.nih.gov/pubmed/37829643
http://dx.doi.org/10.1155/2023/9870758
_version_ 1785119141670158336
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10567496
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105674962023-10-12 Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-10-04 /pmc/articles/PMC10567496/ /pubmed/37829643 http://dx.doi.org/10.1155/2023/9870758 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
title Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
title_full Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
title_fullStr Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
title_full_unstemmed Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
title_short Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
title_sort retracted: fscn1 promotes glycolysis and epithelial-mesenchymal transition in prostate cancer through a yap/taz signaling pathway
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567496/
https://www.ncbi.nlm.nih.gov/pubmed/37829643
http://dx.doi.org/10.1155/2023/9870758
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retractedfscn1promotesglycolysisandepithelialmesenchymaltransitioninprostatecancerthroughayaptazsignalingpathway

Ejemplares similares